Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Bay Colony Advisory Group Inc d b a Bay Colony Advisors

Bay Colony Advisory Group Inc d b a Bay Colony Advisors reduced its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 430 shares of the medical equipment provider’s stock after selling 24 shares during the quarter. Bay Colony Advisory Group Inc d b a Bay Colony Advisors’ holdings in Intuitive Surgical were worth $224,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Bennett Selby Investments LP increased its holdings in Intuitive Surgical by 3.9% in the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock valued at $234,000 after buying an additional 17 shares during the last quarter. Onefund LLC increased its holdings in Intuitive Surgical by 1.9% in the fourth quarter. Onefund LLC now owns 947 shares of the medical equipment provider’s stock valued at $494,000 after buying an additional 18 shares during the last quarter. LVW Advisors LLC increased its holdings in Intuitive Surgical by 1.3% in the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock valued at $756,000 after buying an additional 19 shares during the last quarter. Wesbanco Bank Inc. increased its holdings in Intuitive Surgical by 1.6% in the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock valued at $635,000 after buying an additional 19 shares during the last quarter. Finally, FSM Wealth Advisors LLC increased its holdings in Intuitive Surgical by 3.7% in the fourth quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider’s stock valued at $275,000 after buying an additional 19 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $518.26 on Friday. The company has a market capitalization of $184.59 billion, a PE ratio of 80.85, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The stock has a fifty day moving average of $571.36 and a 200-day moving average of $531.53.

Insiders Place Their Bets

In other Intuitive Surgical news, CFO Jamie Samath sold 269 shares of the stock in a transaction on Monday, February 10th. The shares were sold at an average price of $590.00, for a total transaction of $158,710.00. Following the transaction, the chief financial officer now directly owns 3,282 shares of the company’s stock, valued at $1,936,380. This represents a 7.58 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Mark Brosius sold 489 shares of the company’s stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $533.18, for a total transaction of $260,725.02. Following the sale, the senior vice president now owns 2,091 shares of the company’s stock, valued at $1,114,879.38. This trade represents a 18.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 13,579 shares of company stock valued at $7,756,844 over the last three months. 0.90% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on ISRG shares. JPMorgan Chase & Co. boosted their price objective on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Bernstein Bank upped their target price on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a report on Monday, January 27th. Truist Financial upped their target price on Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a report on Friday, January 24th. Royal Bank of Canada upped their target price on Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Finally, Leerink Partners upped their target price on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have given a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.